Coverage / TRIB / Trade Card

TRIB

Trinity Biotech PLC

SPECULATIVE BUY 2026-08-01 Updated today USD 11.60 Healthcare - Medical - Diagnostics & ResearchAWAIT ENTRY
49

Position levels

Currenttoday
USD 11.60
Buy <=wait / entry
USD 8.00
Trim >=take some off
USD 14.00
Thesis breakA confirmed dilutive equity raise at a material discount to the prevailing share...
-

Scenario-weighted conviction

ProbabilityScoreContribution
Bull case16%100 / 10016.0
Base case48%62 / 10029.8
Bear case36%10 / 1003.6
Weighted conviction49 / 100 - SPECULATIVE BUY

Top risks

  • Strategic collaboration to advance EpiCapture Prostate Cancer Test
  • Q2 2025 revenue decline of 41.9% YoY to $9.2M with gross profit down 43.1%
  • Q4 2025 EPS miss of -$0.90 vs est -$0.31
Read full report →

Research is for informational purposes only. Not financial advice. All analysis reflects the date of publication.